| Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: Current targets and future perspective V Kumar, S Kundu, A Singh, S Singh Current Neuropharmacology 20 (1), 158, 2022 | 87 | 2022 |
| What happens in TBI? A wide talk on animal models and future perspective. S Kundu, S Singh Current neuropharmacology 21 (5), 1139-1164, 2023 | 10 | 2023 |
| Does the long-term administration of proton pump inhibitors increase the risk of adverse cardiovascular outcomes? A ChatGPT powered umbrella review Eleftherios, Aristi, Victoria, Satyabrata, Balpreet, Christodoulos Acta Cardiologica, 2023 | 9 | 2023 |
| A mini review on Calotropis procera and tapping its phytochemical and pharmacological potential S Kundu The journal of phytopharmacology, 2021 | 5 | 2021 |
| Studies on Apigenin and Its Biological and Pharmacological Activity in Brain Disorders V Kumar, S Kundu Advanced Pharmaceutical Bulletin 12 (4), 645, 2022 | 2 | 2022 |
| Protective Mechanisms of 3-Acetyl-11-keto-β-Boswellic Acid and Piperine in Fluid Percussion Rat Model of Traumatic Brain Injury Targeting Nrf2 and NFkB Signaling S Kundu, S Singh Neurotoxicity Research 41 (1), 57-84, 2023 | 1 | 2023 |
| Somatic mutation: Pharmacogenomics in oncology care S Kundu, S Srivastava, S Singh Biomarkers in Cancer Detection and Monitoring of Therapeutics, 329-356, 2024 | | 2024 |
| Genomic Variation and Treatment Strategies of COVID-19: A Descriptive Review S Kundu, S Singh The Open COVID Journal 1 (1), 6-19, 2021 | | 2021 |
